Search Results

Factors associated with the number of drugs in darunavir/cobicistat regimens.

• Authors : Martinez, Esteban; Negredo, Eugenia; Knobel, Hernando

Subjects: RITONAVIR; DARUNAVIR; HIV infectionsSPAIN

• Source: Journal of Antimicrobial Chemotherapy (JAC); Jan2020, Vol. 75 Issue 1, p208-214, 7p

Record details

Brooklyn Hospital Center Researcher Targets HIV/AIDS (Real World Data of Viral Suppression With Darunavir/Cobicistat and Dolutegravir/Rilpivirine Among Treatment-Experienced Patients Living With Multidrug-Resistant HIV).

Subjects: AIDS; DOLUTEGRAVIR; DARUNAVIR

• Source: AIDS Weekly; 5/13/2024, p30-30, 1p

Record details

Simplification of ART in a patient living with multidrug resistant HIV-1: A case report using twice daily cobicistat and darunavir.

• Authors : Brizzi, Marisa B; Novak, Richard M; Chiampas, Thomas D

Subjects: HIV; ANTIRETROVIRAL agents; HIV-positive persons

• Source: International Journal of STD & AIDS; Nov2019, Vol. 30 Issue 13, p1333-1336, 4p, 1 Chart

Record details

Study Results from University Hospital Germans Trias i Pujol Provide New Insights into HIV/AIDS (A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2...).

Subjects: DARUNAVIR; DOLUTEGRAVIR; AIDSCATALONIA (Spain)

• Source: AIDS Weekly; 12/11/2023, p130-130, 1p

Record details

Findings from University Hospital Basel Broaden Understanding of HIV/AIDS (Switch from a ritonavir to a cobicistat containing antiretroviral regimen and impact on tacrolimus levels in a kidney transplant recipient).

Subjects: KIDNEY transplantation; RITONAVIR; AIDS

• Source: AIDS Weekly; 5/22/2023, p51-51, 1p

Record details

Ibalizumab‐uiyk as a bridge therapy for a patient with drug‐resistant HIV‐1 infection receiving chemotherapy: A case report.

• Authors : Dickter, Jana K.¹ ; Martin, Abigail L.¹; Ho, Stephanie²

Subjects: *THERAPEUTIC use of monoclonal antibodies; *HIV infections; *CANCER chemotherapy

• Source: Journal of Clinical Pharmacy & Therapeutics. Aug2021, Vol. 46 Issue 4, p1185-1187. 3p.

Record details

New Findings on HIV/AIDS from Polytechnic University Hospital la Fe Summarized (Observational Study To Evaluate Discontinuation of Monotherapy With Cobicistat-boosted Darunavir In Patients With Human Immunodeficiency Virus).

Subjects: HIV; DARUNAVIR; AIDSVALENCIA (Spain)

• Source: Drug Week; 4/7/2023, p1185-1185, 1p

Record details

A review of drug-drug interactions in older HIV-infected patients.

• Authors : Chary, Aarthi; Nguyen, Nancy N.; Maiton, Kimberly

Subjects: HIV-positive persons; HIV infections; THERAPEUTICS

• Source: Expert Review of Clinical Pharmacology; Dec2017, Vol. 10 Issue 12, p1329-1352, 24p

Record details

Effectiveness and safety of darunavir/cobicistat/emtricitabine/tenofovir alafenamide therapy in an observational Italian cohort: the DIAMANTE study.

• Authors : Antinori, Andrea; Vergori, Alessandra; Ripamonti, Diego

• Source: Future Virology; Jun2023, Vol. 18 Issue 8, p479-488, 10p

Record details

POSB118 Cost-Effectiveness of Elvitegravir, Cobicistat, Emtricitabine and Tenofovir Alafenamide Fumarate Tablets in Acquired Immunodeficiency Syndrome from the Chinese Payer Perspective.

• Authors : Hu, M¹ (AUTHOR); Zhao, J¹ (AUTHOR)

Subjects: *AIDS; *EMTRICITABINE-tenofovir; *COST effectiveness

• Source: Value in Health. 2022 Supplement, Vol. 25 Issue 1, pS84-S84. 1p.

Record details